Search alternatives:
significant barriers » significant barrier (Expand Search), significant factors (Expand Search), significant burden (Expand Search)
barriers decrease » larger decrease (Expand Search), barrier disease (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), we decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 141 - 160 results of 1,472 for search '(( significant barriers decrease ) OR ( significant ((side decrease) OR (step decrease)) ))', query time: 0.59s Refine Results
  1. 141
    Flow Chart of the Study Steps.

    Flow Chart of the Study Steps. by Azam Hosseinpour (13434515)

    Published 2025
    Save to List
    Saved in:
  2. 142
    Experimental setup.

    Experimental setup. by Shinnosuke Hase (20917896)

    Published 2025
    “…Conversely, the fast-rhythm auditory guide significantly increased step rate and decreased step length (p <  0.05). …”
    Save to List
    Saved in:
  3. 143
    Mean muscle activation patterns across the gait cycle during walking with mediolateral (ML) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke during Unsupported Walking (UW; black), 10% BWS + ML (blue) and 30% BWS + ML (red).

    Mean muscle activation patterns across the gait cycle during walking with mediolateral (ML) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke duri... by Sanne Ettema (18786312)

    Published 2025
    Save to List
    Saved in:
  4. 144
    Mean muscle activation patterns across the gait cycle during walking with anteroposterior (AP) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke during Unsupported Walking (UW; black), anterior forces (green) and posterior forces (purple).

    Mean muscle activation patterns across the gait cycle during walking with anteroposterior (AP) forces for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke d... by Sanne Ettema (18786312)

    Published 2025
    Save to List
    Saved in:
  5. 145
    Mean muscle activation patterns across the gait cycle during walking with Body Weight Support (BWS) for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke during Unsupported Walking (UW; black), 10% BWS (blue) and 30% BWS (red).

    Mean muscle activation patterns across the gait cycle during walking with Body Weight Support (BWS) for <i>A)</i> able-bodied individuals and <i>B)</i> individuals after stroke dur... by Sanne Ettema (18786312)

    Published 2025
    Save to List
    Saved in:
  6. 146
    Fig 1 -

    Fig 1 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 147
    Fig 8 -

    Fig 8 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 148
    Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells.

    Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 149
    Fig 4 -

    Fig 4 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 150
    Fig 9 -

    Fig 9 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 151
    Trypan blue dye exclusion assay for cell viability evaluation (% of control).

    Trypan blue dye exclusion assay for cell viability evaluation (% of control). by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 152
    Fig 7 -

    Fig 7 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 153
    Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C).

    Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 154
    Fig 10 -

    Fig 10 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 155
    Fig 5 -

    Fig 5 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 156
    Fig 6 -

    Fig 6 - by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 157
    Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C).

    Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). by Farshid Maleki (20521649)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 158
    Everolimus decreased IgA1 deposits in glomeruli of α1<sup>KI</sup>CD89<sup>Tg</sup> mice.

    Everolimus decreased IgA1 deposits in glomeruli of α1<sup>KI</sup>CD89<sup>Tg</sup> mice. by Alexandra Cambier (22307216)

    Published 2025
    Save to List
    Saved in:
  19. 159
    Everolimus decreased mesangial TfR1 expression in α1<sup>KI</sup>CD89<sup>Tg</sup> mice.

    Everolimus decreased mesangial TfR1 expression in α1<sup>KI</sup>CD89<sup>Tg</sup> mice. by Alexandra Cambier (22307216)

    Published 2025
    Save to List
    Saved in:
  20. 160
    Average Gait Speed (A), Cadence (B), Step Length (C), and Walk Ratio (D) across Terrains; Violin plots with individual participant data of A) gait speed, B) cadence, C) average step length, and D) walk ratio across terrains.

    Average Gait Speed (A), Cadence (B), Step Length (C), and Walk Ratio (D) across Terrains; Violin plots with individual participant data of A) gait speed, B) cadence, C) average ste... by Benjamin S. Killen (22766029)

    Published 2025
    Save to List
    Saved in:

Search Tools: